[{"address1": "55 University Avenue", "address2": "Suite 1003", "city": "Toronto", "state": "ON", "zip": "M5J 2H7", "country": "Canada", "phone": "833 571 1811", "website": "https://www.quantumbiopharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Lakshmi P. Kotra BPHARM, Ph.D.", "age": 53, "title": "CEO of Lucid & Director", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrzej  Chruscinski M.D., Ph.D.", "title": "Vice President of Clinical & Scientific Affairs", "fiscalYear": 2024, "totalPay": 178208, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ashwini  Joshi", "title": "Director of Pharmaceutical Development", "fiscalYear": 2024, "totalPay": 89397, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason D. Sawyer", "age": 31, "title": "Head of Finance & Mergers and Acquisitions", "yearBorn": 1993, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maryann  Adesso", "title": "Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Randell  Mack", "title": "President of FSD BioSciences", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  Cassidy", "title": "Vice President of Quality-Lucid", "fiscalYear": 2024, "totalPay": 144822, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 17.25, "open": 17.4, "dayLow": 16.48, "dayHigh": 17.5, "regularMarketPreviousClose": 17.25, "regularMarketOpen": 17.4, "regularMarketDayLow": 16.48, "regularMarketDayHigh": 17.5, "payoutRatio": 0.0, "beta": 1.62, "forwardPE": -2.1602564, "volume": 54969, "regularMarketVolume": 54969, "averageVolume": 249315, "averageVolume10days": 101070, "averageDailyVolume10Day": 101070, "bid": 12.28, "ask": 21.42, "bidSize": 2, "askSize": 2, "marketCap": 64315440, "fiftyTwoWeekLow": 2.7, "fiftyTwoWeekHigh": 38.25, "fiftyDayAverage": 21.7964, "twoHundredDayAverage": 10.902225, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 63317076, "profitMargins": 0.0, "floatShares": 3407704, "sharesOutstanding": 3816940, "sharesShort": 82353, "sharesShortPriorMonth": 136544, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0216, "heldPercentInsiders": 0.10745, "heldPercentInstitutions": 0.25011, "shortRatio": 0.45, "shortPercentOfFloat": 0.0221, "impliedSharesOutstanding": 3853070, "bookValue": 1.085, "priceToBook": 15.529954, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -27017224, "trailingEps": -11.4, "forwardEps": -7.8, "lastSplitFactor": "1:65", "lastSplitDate": 1723680000, "enterpriseToEbitda": -3.485, "52WeekChange": 3.654696, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 16.85, "targetHighPrice": 17.242434, "targetLowPrice": 17.242434, "targetMeanPrice": 17.242434, "targetMedianPrice": 17.242434, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 1528362, "totalCashPerShare": 0.401, "ebitda": -18168470, "totalDebt": 2265140, "quickRatio": 0.359, "currentRatio": 0.781, "debtToEquity": 110.655, "returnOnAssets": -0.76418996, "returnOnEquity": -4.56814, "freeCashflow": -4203107, "operatingCashflow": -10506541, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QNTM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "regularMarketChangePercent": -2.31884, "regularMarketPrice": 16.85, "postMarketChangePercent": 0.890205, "postMarketPrice": 17.0, "postMarketChange": 0.15, "regularMarketChange": -0.4, "regularMarketDayRange": "16.48 - 17.5", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 249315, "fiftyTwoWeekLowChange": 14.150001, "fiftyTwoWeekLowChangePercent": 5.240741, "fiftyTwoWeekRange": "2.7 - 38.25", "fiftyTwoWeekHighChange": -21.4, "fiftyTwoWeekHighChangePercent": -0.5594771, "fiftyTwoWeekChangePercent": 365.4696, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -11.4, "epsForward": -7.8, "fiftyDayAverageChange": -4.9463997, "fiftyDayAverageChangePercent": -0.22693655, "twoHundredDayAverageChange": 5.947776, "twoHundredDayAverageChangePercent": 0.5455562, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "FSD Pharma Inc.", "nameChangeDate": "2025-08-29", "averageAnalystRating": "1.0 - Strong Buy", "shortName": "Quantum Biopharma Ltd.", "longName": "Quantum BioPharma Ltd.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1528464600000, "corporateActions": [], "postMarketTime": 1756510505, "regularMarketTime": 1756497600, "exchange": "NCM", "messageBoardId": "finmb_266208867", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Quantum BioPharma", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]